reference/12253636

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12253636

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	5093
issn	0008-543X 1097-0142
issueIdentifier	22
pageRange	5085-5093
publicationName	Cancer
startingPage	5085
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ab80a732b5df33e85751c0a758afb577 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_bcb538be81300dc8e034ad1c63fc7600
bibliographicCitation	Quintás-Cardama A, Kantarjian H, Shan J, Jabbour E, Abruzzo LV, Verstovsek S, Garcia-Manero G, O'Brien S, Cortes J. Prognostic impact of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia treated with nilotinib or dasatinib. Cancer. 2011 Nov 15;117(22):5085–93. PMID: 21523765; PMCID: PMC4324753.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c8c1de7da4deb440ed2ecc8697edce38 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_daa43bea25ac904aced022cc20b96d9b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f66ab640a0521794a57ea369ea04078e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8796f12e28a415774f96967e3d96504e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b010671c2d90c083d5256b16afb62beb http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8636-1071 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bc34ddc88a28e12990e522742a21f0cb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2179b74e09e09468d620914757116d27 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cbef71c6c9ee38c2d2fb7df759bcb6c6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_98246eabf16e75d088310ed84ef52e0c
date	2011-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC4324753 https://pubmed.ncbi.nlm.nih.gov/21523765 https://doi.org/10.1002/cncr.26147
isPartOf	https://portal.issn.org/resource/ISSN/1097-0142 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2771 https://portal.issn.org/resource/ISSN/0008-543X
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Prognostic impact of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia treated with nilotinib or dasatinib
discusses	http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0470497 http://id.nlm.nih.gov/mesh/M0017888 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0018260 http://id.nlm.nih.gov/mesh/M0021333 http://id.nlm.nih.gov/mesh/M0482811
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D013844Q000627 http://id.nlm.nih.gov/mesh/D011743Q000627 http://id.nlm.nih.gov/mesh/D047428Q000627 http://id.nlm.nih.gov/mesh/D015464Q000188 http://id.nlm.nih.gov/mesh/D002899 http://id.nlm.nih.gov/mesh/D000970Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D015464Q000235 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D000069439 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D011505Q000037 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D017384 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D018572 http://id.nlm.nih.gov/mesh/D015464Q000401 http://id.nlm.nih.gov/mesh/D008875
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7055 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3062316 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3657 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9727 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644241 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7d6a1edc08997e3d7b61d7a07051efb5

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247851103 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129520807 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129879136 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128433595

Total number of triples: 75.